HHPD

13.8

+1.47%↑

NVDA

170.91

+1.58%↑

MSFT

498.64

+0.12%↑

AAPL

234.45

-1.39%↓

AVGO.US

336.58

-2.5%↓

HHPD

13.8

+1.47%↑

NVDA

170.91

+1.58%↑

MSFT

498.64

+0.12%↑

AAPL

234.45

-1.39%↓

AVGO.US

336.58

-2.5%↓

HHPD

13.8

+1.47%↑

NVDA

170.91

+1.58%↑

MSFT

498.64

+0.12%↑

AAPL

234.45

-1.39%↓

AVGO.US

336.58

-2.5%↓

HHPD

13.8

+1.47%↑

NVDA

170.91

+1.58%↑

MSFT

498.64

+0.12%↑

AAPL

234.45

-1.39%↓

AVGO.US

336.58

-2.5%↓

HHPD

13.8

+1.47%↑

NVDA

170.91

+1.58%↑

MSFT

498.64

+0.12%↑

AAPL

234.45

-1.39%↓

AVGO.US

336.58

-2.5%↓

Kodu・Aktsiate loetelu・Azenta Inc

Azenta Inc

Suletud

SektorTehnoloogia

29.41 -0.14

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

29.07

Max

29.54

Põhinäitajad
By Trading Economics
Sissetulek	41M 680K
Müük	524K 144M
Kasumimarginaal	0.472
Töötajad	3,000
EBITDA	36M 18M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+17.41% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	11. nov 2025

Turustatistika
By TradingEconomics
Turukapital	-133M 1.4B
Eelmine avamishind	29.55
Eelmine sulgemishind	29.41

Uudiste sentiment

By Acuity

50%

175 / 407 Pingereas Technology

Azenta Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

9. sept 2025, 23:37 UTC

Kuumad aktsiad

Stocks to Watch: Oracle, Wearable Devices, GameStop

9. sept 2025, 20:41 UTC

Tulu

Oracle's Backlog Surges With Major Customer Deals in 1Q

9. sept 2025, 20:30 UTC

Tulu

GameStop 2Q Sales, Profit Rise

9. sept 2025, 23:19 UTC

Market Talk

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

9. sept 2025, 21:35 UTC

Tulu

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

9. sept 2025, 21:32 UTC

Tulu

Oracle's Backlog Swells With Big Customer Deals -- Update

9. sept 2025, 21:02 UTC

Omandamised, ülevõtmised, äriostud

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

9. sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. sept 2025, 20:33 UTC

Tulu

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

9. sept 2025, 20:26 UTC

Tulu

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9. sept 2025, 20:23 UTC

Tulu

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9. sept 2025, 20:12 UTC

Tulu

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

9. sept 2025, 20:10 UTC

Tulu

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

9. sept 2025, 20:10 UTC

Tulu

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

9. sept 2025, 20:09 UTC

Tulu

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

9. sept 2025, 20:09 UTC

Tulu

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

9. sept 2025, 20:08 UTC

Tulu

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

9. sept 2025, 20:08 UTC

Tulu

Oracle 1Q Operating Income Was $4.3 B >ORCL

9. sept 2025, 20:08 UTC

Tulu

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

9. sept 2025, 20:08 UTC

Tulu

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

9. sept 2025, 20:07 UTC

Tulu

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

9. sept 2025, 20:06 UTC

Tulu

Oracle 1Q Software Revenue $5.72B >ORCL

9. sept 2025, 20:06 UTC

Tulu

Synopsys 3Q Adj EPS $3.39 >SNPS

9. sept 2025, 20:06 UTC

Tulu

Oracle 1Q Cloud Revenue $7.19B >ORCL

9. sept 2025, 20:05 UTC

Tulu

Oracle 1Q Rev $14.93B >ORCL

9. sept 2025, 20:05 UTC

Tulu

Oracle 1Q EPS $1.01 >ORCL

9. sept 2025, 20:05 UTC

Tulu

Synopsys 3Q EPS $1.50 >SNPS

9. sept 2025, 20:05 UTC

Tulu

Oracle 1Q Services Revenue $1.35B >ORCL

9. sept 2025, 20:05 UTC

Tulu

Oracle 1Q Adj EPS $1.47 >ORCL

9. sept 2025, 20:05 UTC

Tulu

Oracle 1Q Hardware Revenue $670M >ORCL

Võrdlus sarnastega

Hinnamuutus

Azenta Inc Prognoos

Hinnasiht

By TipRanks

17.41% tõus

12 kuu keskmine prognoos

Keskmine 34.6 USD 17.41%

Kõrge 40 USD

Madal 30 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Azenta Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

5 ratings

Osta

Hoia

Müü

Põhineb 5 analüütiku instrumendi Azenta Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

175 / 407 Pingereas Tehnoloogia

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Azenta Inc

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.